Larson Financial Group’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$21.4K Sell
329
-2
-0.6% -$91 ﹤0.01% 2065
2026
Q2
$9.43K Buy
331
+33
+11% +$718 ﹤0.01% 2447
2026
Q1
$5.17K Sell
298
-15
-5% -$284 ﹤0.01% 2596
2025
Q4
$5.9K Buy
313
+236
+306% +$3.95K ﹤0.01% 2390
2025
Q3
$1.12K Buy
+77
New +$1.1K ﹤0.01% 2887

Other funds holding CDNA

Larson Financial Group's CDNA Position: Q3 2026 in Review

Larson Financial Group reduced its CareDx (CDNA) stake by 0.6% in Q3 2026, selling an estimated $91 and leaving 329 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Larson Financial Group first reported a position in CDNA in Q3 2025 and has held it in 5 quarters since. 140 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • Larson Financial Group held 329 shares of CareDx worth $21.4K as of Q3 2026.
  • Larson Financial Group sold 2 CareDx shares in Q3 2026, an estimated $91.
  • CareDx made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2065 holding.
  • Larson Financial Group first reported a position in CareDx in Q3 2025 and has held it in 5 quarters since.
  • 140 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.